Presentation is loading. Please wait.

Presentation is loading. Please wait.

Characterization of Small Molecule ETS Transcription Factor Binders Nicole M. Martinez Marius S. Pop and Levi A. Garraway Cancer Biology Program.

Similar presentations


Presentation on theme: "Characterization of Small Molecule ETS Transcription Factor Binders Nicole M. Martinez Marius S. Pop and Levi A. Garraway Cancer Biology Program."— Presentation transcript:

1 Characterization of Small Molecule ETS Transcription Factor Binders Nicole M. Martinez Marius S. Pop and Levi A. Garraway Cancer Biology Program

2 Targeted Therapy in Cancer “Druggable” targets –Obvious active site Kinases Other enzymes “Undruggable” targets –No obvious pocket DOI:10.1038/nrd2275

3 Many “Driver” Cancer Proteins are Currently “Undruggable” Example: Oncogenic Transcription Factors –ETS Transcription Factors Translocated in >50% of prostate cancers ETV1 ERG Otis Brawley, National Cancer Institute Prostate Tumor

4 ETS Transcription Factor Role in Prostate Cancer /ETV1 doi:10.1038/nm0106-14

5 Can we develop a therapeutic?

6 DMSO stock solutions protein-small molecule interaction on a microarray aMouse-IgG-Cy5 ETV1 fluorescent features reveal putative binding interactions Small-Molecule Microarrays (SMMs) ha.11 Lysates expressing target protein αHA MITF ETV1 ERG truncated ERG full

7 f = microarray feature median pixel intensity b = local background median pixel intensity x cpd = f - b 1.253.756.25Z* Overlay of GAL File Z* =  cpd - µ mock  mock ( 1+1+ )  cpd 0.96 From Raw Data to Hits

8 ETV1 Selection of Hits ZScoreA ZScoreB ZScoreC CompositeZ

9 ChemBank: Tool for Filtering Compounds http://chembank.broad.harvard.edu

10 List of ETS “Hit” Compounds *LibraryHEK-293T cell lysate MITFETV1ERGtERG NPC22873130 PDI631581 NPC: Natural Products and commercials (Including FDA approved drugs) library PDI: Psychiatric Disease Initiative compounds *10,800 compounds per library

11 Assess Inhibitory Capabilities by Luciferase Assays ETSLuciferase ERG rep rep + ERG rep + ERG + compound Fold

12 Lead Compounds Cpd1 Cpd2

13 Assess Inhibitory Capabilities by Luciferase Assays ETSLuciferase ERG rep rep + ERG rep + ERG + compound Fold

14 Dud Compounds Ctrl DMSO ERG cpds A B C D MITFETV1 Ctrl ERG cpds Ctrl tERG cpds A B C D MITF ETV1

15 Conclusions SMM allow us to find binders Luciferase assays allow us to determine inhibitory capabilities Future work –Surface Plasmon Resonance –Screen w/ more compounds

16 Acknowledgements Mentors Marius Pop, PhD Levi Garraway, MD, PhD Collaborators Angela Koehler, PhD Jason Fuller Summer Research Program in Genomics Shawna Young Lucia Vielma Bruce Birren, PhD

17 ETS Fusion Products Exon 1 of TMPRSS2 with the beginning of exon 4 of ETV1 Exons 1 and 2 of TMPRSS2 with the beginning of exon 4 of ETV1 Exon 1 of TMPRSS2 with the beginning of exon 4 of ERG


Download ppt "Characterization of Small Molecule ETS Transcription Factor Binders Nicole M. Martinez Marius S. Pop and Levi A. Garraway Cancer Biology Program."

Similar presentations


Ads by Google